| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.86 | 0.004 | 0.861 | Hypoglycemic | 0.861 0.004 CID_192219 0.833 0.004 CID_131750725 0.813 0.004 CID_75051323 | CID_192219 | |
| 0.694 | 0.004 | 0.694 | MAP kinase kinase 6 inhibitor | 0.605 0.005 CID_192219 0.628 0.005 CID_131750725 0.621 0.005 CID_75051323 | ||
| 0.666 | 0.014 | 0.672 | Antiobesity | 0.672 0.013 CID_192219 0.631 0.017 CID_131750725 0.569 0.025 CID_75051323 | CID_192219 | |
| 0.62 | 0.024 | 0.695 | Cyclophilin D inhibitor | 0.695 0.015 CID_192219 0.657 0.019 CID_131750725 0.607 0.026 CID_75051323 | CID_192219 | |
| 0.537 | 0.005 | 0.537 | Platelet adhesion inhibitor | 0.523 0.005 CID_192219 0.532 0.005 CID_131750725 0.52 0.005 CID_75051323 | ||
| 0.48 | 0.003 | 0.48 | M18 aspartyl aminopeptidase inhibitor | 0.451 0.004 CID_192219 0.462 0.004 CID_131750725 0.454 0.004 CID_75051323 | ||
| 0.478 | 0.032 | 0.596 | Antithrombotic | 0.596 0.017 CID_192219 0.589 0.017 CID_131750725 0.571 0.019 CID_75051323 | CID_192219 | |
| 0.381 | 0.014 | 0.381 | Diuretic | 0.282 0.026 CID_192219 0.334 0.018 CID_131750725 0.328 0.018 CID_75051323 | ||
| 0.362 | 0.004 | 0.362 | Cannabinoid receptor antagonist | 0.218 0.007 CID_192219 0.164 0.012 CID_131750725 0.093 0.032 CID_75051323 | ||
| 0.352 | 0.005 | 0.358 | Cyclin-dependent kinase 3 inhibitor | 0.358 0.005 CID_192219 0.311 0.008 CID_131750725 0.299 0.009 CID_75051323 | CID_192219 | |
| 0.396 | 0.076 | 0.396 | 15-Lipoxygenase inhibitor | 0.292 0.137 CID_192219 0.346 0.102 CID_131750725 0.212 0.2 CID_75051323 | ||
| 0.32 | 0.004 | 0.32 | Cannabinoid CB1 receptor antagonist | 0.195 0.005 CID_192219 0.135 0.009 CID_131750725 0.084 0.024 CID_75051323 | ||
| 0.226 | 0.006 | 0.286 | Adenylate cyclase stimulant | 0.242 0.004 CID_192219 0.272 0.004 CID_131750725 0.286 0.003 CID_75051323 | CID_75051323 | |
| 0.276 | 0.059 | 0.276 | 5 Hydroxytryptamine uptake stimulant | 0.262 0.07 CID_192219 0.214 0.126 CID_131750725 0.201 0.149 CID_75051323 | ||
| 0.2 | 0.009 | 0.225 | Carbonic anhydrase inhibitor | 0.201 0.009 CID_192219 0.225 0.007 CID_131750725 0.18 0.012 CID_75051323 | CID_131750725 | |
| 0.277 | 0.093 | 0.277 | 12-Lipoxygenase inhibitor | 0.23 0.122 CID_192219 0.197 0.155 CID_131750725 | ||
| 0.273 | 0.105 | 0.411 | Sodium/bile acid cotransporter inhibitor | 0.283 0.095 CID_192219 0.386 0.021 CID_131750725 0.411 0.014 CID_75051323 | CID_75051323 | |
| 0.168 | 0.004 | 0.168 | Potassium channel (ATP-sensitive) blocker | 0.134 0.006 CID_192219 0.155 0.005 CID_131750725 0.109 0.012 CID_75051323 | ||
| 0.193 | 0.039 | 0.201 | Insulin secretagoues | 0.201 0.035 CID_192219 0.195 0.039 CID_131750725 0.171 0.055 CID_75051323 | CID_192219 | |
| 0.155 | 0.004 | 0.155 | Bombesin 3 receptor antagonist | 0.145 0.004 CID_192219 0.137 0.005 CID_131750725 0.131 0.005 CID_75051323 | ||
| 0.146 | 0.008 | 0.146 | Cannabinoid CB2 receptor antagonist | 0.091 0.017 CID_192219 0.062 0.028 CID_131750725 | ||
| 0.133 | 0.005 | 0.133 | Potassium channel (Inward rectifier) blocker | 0.103 0.006 CID_192219 0.119 0.005 CID_131750725 0.074 0.015 CID_75051323 | ||
| 0.21 | 0.086 | 0.21 | Potassium channel blocker | |||
| 0.133 | 0.012 | 0.153 | Carbonic anhydrase I inhibitor | 0.125 0.013 CID_192219 0.153 0.01 CID_131750725 0.111 0.016 CID_75051323 | CID_131750725 | |
| 0.133 | 0.014 | 0.133 | Carbonic anhydrase IX inhibitor | 0.126 0.015 CID_192219 0.089 0.023 CID_131750725 0.059 0.038 CID_75051323 | ||
| 0.131 | 0.015 | 0.131 | Carbonic anhydrase XII inhibitor | 0.121 0.016 CID_192219 0.09 0.022 CID_131750725 0.048 0.04 CID_75051323 | ||
| 0.126 | 0.014 | 0.146 | Carbonic anhydrase II inhibitor | 0.123 0.014 CID_192219 0.146 0.01 CID_131750725 0.113 0.016 CID_75051323 | CID_131750725 | |
| 0.108 | 0.004 | 0.108 | Carbonic anhydrase I stimulant | 0.091 0.005 CID_192219 0.087 0.006 CID_131750725 0.079 0.007 CID_75051323 | ||
| 0.137 | 0.037 | 0.137 | CDK3/cyclin E inhibitor | 0.135 0.039 CID_192219 0.112 0.067 CID_131750725 0.099 0.089 CID_75051323 | ||
| 0.101 | 0.005 | 0.101 | Carbonic anhydrase II stimulant | 0.087 0.007 CID_192219 0.084 0.008 CID_131750725 0.078 0.01 CID_75051323 | ||
| 0.203 | 0.113 | 0.203 | MAP kinase kinase 3 inhibitor | 0.183 0.179 CID_131750725 | ||
| 0.183 | 0.095 | 0.183 | Platelet aggregation inhibitor | 0.164 0.112 CID_192219 0.18 0.097 CID_131750725 | ||
| 0.118 | 0.038 | 0.118 | Electrolyte absorption antagonist | 0.093 0.068 CID_192219 0.093 0.068 CID_131750725 | ||
| 0.097 | 0.026 | 0.131 | Carbonic anhydrase VA inhibitor | 0.131 0.015 CID_192219 0.071 0.045 CID_131750725 | CID_192219 | |
| 0.132 | 0.062 | 0.132 | CC chemokine 6 receptor antagonist | 0.125 0.089 CID_192219 0.127 0.083 CID_131750725 0.128 0.079 CID_75051323 | ||
| 0.093 | 0.022 | 0.093 | Bcl2 antagonist | 0.091 0.024 CID_192219 0.082 0.03 CID_131750725 0.07 0.042 CID_75051323 | ||
| 0.091 | 0.021 | 0.091 | Carbonic anhydrase stimulant | 0.059 0.041 CID_192219 0.062 0.039 CID_131750725 | ||
| 0.091 | 0.03 | 0.15 | Carbonic anhydrase V inhibitor | 0.15 0.014 CID_192219 0.063 0.05 CID_131750725 | CID_192219 | |
| 0.078 | 0.021 | 0.1 | Thromboxane antagonist | 0.1 0.011 CID_192219 0.075 0.023 CID_131750725 0.069 0.027 CID_75051323 | CID_192219 | |
| 0.059 | 0.006 | 0.059 | Estrone sulfatase inhibitor | 0.042 0.008 CID_192219 0.033 0.01 CID_131750725 0.041 0.009 CID_75051323 | ||
| 0.128 | 0.075 | 0.128 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.109 0.092 CID_131750725 | ||
| 0.093 | 0.044 | 0.171 | Carbonic anhydrase VI inhibitor | 0.171 0.017 CID_192219 0.103 0.037 CID_131750725 0.104 0.037 CID_75051323 | CID_192219 | |
| 0.138 | 0.092 | 0.15 | Anticoagulant | 0.15 0.081 CID_192219 0.13 0.1 CID_131750725 | CID_192219 | |
| 0.072 | 0.033 | 0.072 | Cannabinoid CB1 receptor agonist | 0.054 0.048 CID_192219 | ||
| 0.062 | 0.027 | 0.081 | Thromboxane A2 antagonist | 0.081 0.014 CID_192219 0.059 0.029 CID_131750725 0.053 0.034 CID_75051323 | CID_192219 | |
| 0.057 | 0.023 | 0.057 | Alpha 1b adrenoreceptor agonist | |||
| 0.038 | 0.004 | 0.038 | Carbonic anhydrase IV stimulant | 0.028 0.004 CID_192219 0.026 0.005 CID_131750725 0.023 0.005 CID_75051323 | ||
| 0.064 | 0.031 | 0.064 | Bcl-xL inhibitor | 0.064 0.031 CID_192219 0.058 0.047 CID_131750725 | ||
| 0.054 | 0.024 | 0.054 | Collagenase inhibitor | 0.051 0.03 CID_192219 0.05 0.032 CID_131750725 0.046 0.042 CID_75051323 | ||
| 0.13 | 0.1 | 0.139 | Pregnane X receptor agonist | 0.139 0.075 CID_131750725 | CID_131750725 | |
| 0.047 | 0.017 | 0.051 | Aggrecanase 1 inhibitor | 0.051 0.013 CID_192219 0.038 0.029 CID_131750725 0.036 0.034 CID_75051323 | CID_192219 | |
| 0.075 | 0.047 | 0.075 | Thrombin inhibitor | 0.067 0.059 CID_192219 | ||
| 0.067 | 0.043 | 0.067 | Cannabinoid receptor agonist | |||
| 0.133 | 0.109 | 0.133 | Mcl-1 antagonist | |||
| 0.052 | 0.033 | 0.1 | Prostaglandin E2 antagonist | 0.1 0.014 CID_192219 | CID_192219 | |
| 0.058 | 0.042 | 0.058 | Cyclin H inhibitor | |||
| 0.057 | 0.041 | 0.057 | CDK4/cyclin D1 inhibitor | 0.051 0.047 CID_192219 | ||
| 0.058 | 0.042 | 0.058 | Cyclin E inhibitor | |||
| 0.048 | 0.032 | 0.049 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.049 0.03 CID_131750725 0.047 0.032 CID_75051323 | CID_131750725 | |
| 0.04 | 0.023 | 0.04 | Potassium channel Kv1.1 blocker | |||
| 0.018 | 0.005 | 0.018 | CC chemokine 10 receptor antagonist | 0.016 0.009 CID_192219 0.015 0.01 CID_131750725 | ||
| 0.141 | 0.129 | 0.164 | Non-steroidal antiinflammatory agent | 0.15 0.114 CID_192219 0.164 0.1 CID_131750725 | CID_131750725 | |
| 0.071 | 0.06 | 0.071 | GABA aminotransferase inhibitor | |||
| 0.052 | 0.043 | 0.082 | Carbonic anhydrase VB inhibitor | 0.082 0.021 CID_192219 | CID_192219 | |
| 0.057 | 0.05 | 0.057 | CDK1/cyclin B inhibitor | |||
| 0.07 | 0.064 | 0.071 | Vanilloid 4 agonist | 0.071 0.06 CID_192219 | CID_192219 | |
| 0.194 | 0.189 | 0.194 | Beta lactamase inhibitor | |||
| 0.038 | 0.034 | 0.039 | Phenylethanolamine N methyltransferase inhibitor | 0.039 0.032 CID_192219 | CID_192219 | |
| 0.066 | 0.062 | 0.13 | Carbonic anhydrase XIII inhibitor | 0.13 0.026 CID_192219 | CID_192219 | |
| 0.044 | 0.041 | 0.044 | Cyclin E1 inhibitor | |||
| 0.041 | 0.039 | 0.041 | Carbonic anhydrase VII inhibitor | |||
| 0.019 | 0.018 | 0.019 | Factor XIII inhibitor | |||
| 0.045 | 0.044 | 0.045 | HCV NS3/NS4A protease inhibitor | |||
| 0.148 | 0.147 | 0.217 | Platelet antagonist | 0.207 0.096 CID_192219 0.217 0.089 CID_131750725 0.162 0.132 CID_75051323 | CID_131750725 | |
| 0.055 | 0.056 | 0.069 | Prostaglandin F2 alpha antagonist | 0.069 0.034 CID_131750725 0.067 0.035 CID_75051323 | CID_131750725 | |
| 0.025 | 0.026 | 0.032 | Prostaglandin EP3 antagonist | 0.032 0.019 CID_192219 | CID_192219 | |
| 0.085 | 0.092 | 0.13 | Carbonic anhydrase XV inhibitor | 0.13 0.04 CID_192219 | CID_192219 | |
| 0.039 | 0.05 | 0.064 | Carbonic anhydrase XIV inhibitor | 0.064 0.023 CID_192219 | CID_192219 | |
| 0.032 | 0.044 | 0.044 | Carbonic anhydrase IV inhibitor | 0.044 0.029 CID_131750725 | CID_131750725 | |
| 0.05 | 0.064 | 0.062 | Neutrophil collagenase inhibitor | 0.062 0.048 CID_192219 | CID_192219 | |
| 0.026 | 0.044 | 0.053 | Farnesoid X receptor agonist | 0.037 0.027 CID_192219 0.053 0.013 CID_131750725 0.049 0.015 CID_75051323 | CID_131750725 | |
| 0.02 | 0.045 | 0.03 | HCV NS5B polymerase inhibitor | 0.03 0.023 CID_192219 | CID_192219 | |
| 0.025 | 0.05 | 0.031 | RNA-directed RNA polymerase inhibitor | 0.031 0.03 CID_192219 | CID_192219 | |
| 0.03 | 0.057 | 0.045 | Glucose-6-phosphate dehydrogenase inhibitor | 0.045 0.015 CID_131750725 0.036 0.03 CID_75051323 | CID_131750725 | |
| 0.127 | 0.163 | 0.183 | Phospholipase C inhibitor | 0.167 0.077 CID_192219 0.183 0.058 CID_131750725 0.171 0.071 CID_75051323 | CID_131750725 | |
| 0.07 | 0.118 | 0.087 | ABCA1 expression enhancer | 0.087 0.072 CID_75051323 | CID_75051323 | |
| 0.028 | 0.077 | 0.053 | Prostaglandin antagonist | 0.053 0.037 CID_192219 | CID_192219 | |
| 0.066 | 0.263 | 0.135 | Anesthetic general | 0.135 0.131 CID_131750725 | CID_131750725 | |
| 0.079 | 0.341 | 0.269 | Lipocortins synthesis antagonist | 0.139 0.123 CID_131750725 0.269 0.028 CID_75051323 | CID_75051323 | |
| 0.031 | 0.373 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 CID_75051323 | CID_75051323 | |
| 0.039 | 0.412 | 0.118 | Farnesoid X receptor antagonist | 0.118 0.109 CID_131750725 | CID_131750725 | |
| 0.103 | 0.52 | 0.368 | Antiinflammatory | 0.368 0.16 CID_75051323 | CID_75051323 | |
| 0.084 | 0.568 | 0.181 | Peptidyltransferase inhibitor | 0.181 0.127 CID_131750725 | CID_131750725 | |
| 0.015 | 0.526 | 0.1 | Aminoacyl-tRNA synthetase inhibitor | 0.1 0.045 CID_75051323 | CID_75051323 | |
| 0.073 | 0.642 | 0.219 | Interleukin 2 agonist | 0.219 0.158 CID_192219 | CID_192219 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |